new asthma drug, Accolate (zafirlukast)
November 1996
Zeneca is hoping to make a big splash with their new asthma drug, Accolate (zafirlukast).
It's the first drug in a new class...leukotriene receptor antagonists (LTRA). Leukotrienes have been a HUGE area for asthma research...their discovery resulted in a Nobel prize.
Leukotrienes are pro-inflammatory substances. They're released when mast cells are exposed to allergens. In the lung, leukotrienes trigger bronchoconstriction...inflammation...and edema.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote